These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 7550128
1. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus. Kim YS, Sagara J, Kawai A. Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128 [Abstract] [Full Text] [Related]
2. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus. Kim YS, Kawai A. Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507 [Abstract] [Full Text] [Related]
8. Restricted replication of vesicular stomatitis virus in T lymphocytes is coincident with a deficiency in a cellular protein kinase required for viral transcription. Sleat DE, Chikkala NF, Gautam S, Banerjee AK. J Gen Virol; 1992 Dec; 73 ( Pt 12)():3125-32. PubMed ID: 1335023 [Abstract] [Full Text] [Related]
10. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication. Parker J, Ahrens PB, Ankel H. Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950 [Abstract] [Full Text] [Related]
11. Mechanisms of anti-vesicular stomatitis virus activity of deazaneplanocin and its 3-brominated analogs. Gibbons JS, Khadka S, Williams CG, Wang L, Schneller SW, Liu C, Tufariello JM, Basler CF. Antiviral Res; 2021 Jul; 191():105088. PubMed ID: 34019950 [Abstract] [Full Text] [Related]
12. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells. Borghi P, Di Marzio P, Varano B, Conti L, Belardelli F, Gessani S. J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103 [Abstract] [Full Text] [Related]
13. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells. Pica F, Rossi A, Santirocco N, Palamara A, Garaci E, Santoro MG. Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598 [Abstract] [Full Text] [Related]
14. Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells. Lancz G, Whitaker-Dowling P, Marsh YV, Bradley G, Eppstein DA, Hackney JF, Hulick-Swardstrom B. Proc Soc Exp Biol Med; 1990 Mar; 193(3):190-6. PubMed ID: 2154755 [Abstract] [Full Text] [Related]
16. Inhibition of the phosphorylation of the regulatory non-structural protein of vesicular stomatitis virus by an antiviral xanthate compound. Müller-Decker K, Amtmann E, Sauer G. J Gen Virol; 1987 Dec; 68 ( Pt 12)():3045-56. PubMed ID: 2447222 [Abstract] [Full Text] [Related]
17. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD). Zhang XM, He DN, Zhou B, Pang R, Liu K, Zhao J, Chen PY. Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591 [Abstract] [Full Text] [Related]
19. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells. Romanutti C, Castilla V, Coto CE, Wachsman MB. Int J Antimicrob Agents; 2007 Mar 05; 29(3):311-6. PubMed ID: 17275263 [Abstract] [Full Text] [Related]